Form 4: Director J. Robert Kerrey Sells Tenet Healthcare Shares
Statement of Changes in Beneficial Ownership
Tenet Healthcare Director J. Robert Kerrey sold 5,638 shares of common stock on May 28, 2026.
Summary
- Director J. Robert Kerrey executed a series of sales of Tenet Healthcare (THC) common stock on May 28, 2026.
- A total of 5,638 shares were sold across five separate transactions.
- The sales were executed at weighted average prices ranging from $173.12 to $177.52 per share.
- Following these transactions, the director retains 16,804 shares of common stock.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral event, as Form 4 filings regarding insider sales are standard regulatory disclosures and do not inherently signal negative corporate performance.
Positives
- The director maintains a significant remaining equity stake of 16,804 shares in the company.
Negatives
- The filing reflects a reduction in direct ownership by a member of the board of directors.
Risks
- Insider selling can sometimes be perceived by the market as a lack of confidence in future share price appreciation, though these sales are often routine portfolio management.
Future Outlook
NA
Industry Context
StockSavvy.ai notes that director stock sales are common occurrences in the healthcare sector and are frequently executed for personal financial planning or diversification rather than reflecting fundamental changes in company outlook.
Comparison to Industry Standards
- Insider selling by board members is a standard practice in large-cap healthcare companies like HCA Healthcare or Universal Health Services.
- The volume of shares sold represents a small fraction of the director's total holdings, which is consistent with typical executive equity management.
Stakeholder Impact
- Shareholders should monitor for further insider activity, though this specific sale is unlikely to impact long-term corporate strategy.
Next Steps
- No future actions or milestones were disclosed in this filing.
Key Dates
| Date | Description |
|---|---|
| 05/28/2026 | Date of the reported stock sales transactions. |
| 05/29/2026 | Date the Form 4 was signed and filed. |
Keywords
Tenet Healthcare, THC, Insider Trading, Form 4, Director Sale, Equity Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.